Trending
- SOHO-02 Trial Will Confirm Sevabertinib’s Frontline NSCLC Benefit
- Synonymous codon usage shapes ERα function through specialized translational programs during breast cancer progression
- FDA Panel Narrowly Backs Multi-Cancer Blood Test Despite Doubts It Works
- Anselamimab’s Kappa Subgroup Signal Could Reshape Anti-Fibril Therapy in AL Amyloidosis
- Free counselling for blood cancer patients
- When You Can’t Do Things the Way You Used To
- Patient-Centered Treatment Transitions in HR+/HER2− mBC
- Epcoritamab Combo Receives Canadian Approval in R/R Follicular Lymphoma
Thursday, September 24